Antimicrobial Potential of Phytochemicals in the Era of Antibiotic Resistance
A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Plant-Derived Antibiotics".
Deadline for manuscript submissions: 30 September 2026 | Viewed by 389
Special Issue Editor
2. Group of Translational Research in Digestive Diseases, Institute for Health Research Aragon (IIS Aragón), Zaragoza, Spain
Interests: Helicobacter pylori; Clostridioides difficile; novel antimicrobials; precision antibiotics; phytochemicals
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
After decades of significant advances in medicine and technology, multidrug resistance to antibiotics in clinically relevant pathogens has emerged as a global public health problem in the 21st century. The inability to effectively treat some infections with current therapeutic tools is already a reality. Therefore, novel strategies must urgently be implemented to reduce and potentially reverse the increasing emergence, spread and accumulation of antimicrobial resistance in bacterial pathogens.
Humans have used medicinal plants for centuries to treat infections, and thousands of studies strongly support the use of phytochemicals as sources of novel antimicrobials and antibiotic adjuvants. To overcome the current circulating resistome, we should make better use of the vast arsenal of plant-derived bioactive compounds in the development of new classes of antimicrobials and combination therapies. With this Special Issue, we aim to present a collection of high-quality original research articles and reviews that provide evidence of the therapeutic potential of medicinal plants, plant extracts and phytochemicals against human pathogens.
Dr. Andrés González
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- phytochemicals
- medicinal plants
- plant extracts
- antibiotic resistance
- multidrug resistance
- pathogens
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
